BK Medical (Herlev, Denmark), a subsidiary of Analogic (Peabody, Massachusetts), has launched its new ultrasound system, the Pro Focus UltraView, for the surgical and urological ultrasound markets. This high-performance ultrasound system uses BK Medical's new IQPAC technology to provide premium images that make a diagnostic difference. The IQPAC technology combines BK Medical's Enhanced Tissue Definition and Angular Compound Imaging technologies to optimize the ultrasound image. Enhanced Tissue Definition intensifies anatomic borders by minimizing speckle, and Angular Compound Imaging uses images from several angles to create a superior compound image. The UltraView system also features a 19" high-definition monitor with scalable image size and a sealed keyboard for easy cleaning.

• IOPtima (Ramat Gan, Israel) reported the completion of its first six-month follow-up period of human clinical trials. IOPtima's laser-based technology enables eye surgeons to perform a simple and safe surgery and reduce internal eye pressure without penetrating the eye membrane. Elevated internal eye pressure, or intra-ocular pressure (IOP), is a key cause/risk factor of glaucoma, which in many cases causes the deterioration in the visual field and ultimately can lead to blindness without proper treatment to reduce and control IOP. The procedure, using IOPtima technology, was performed with local anesthesia on an out-patient basis, and was demonstrated in these trials to be both safe and efficacious as a means to reduce IOP.

• Medtronic (Minneapolis) reported the first enrollment in VITALITY, the company's post-market clinical study of its Talent Abdominal Stent Graft for the endovascular repair of abdominal aortic aneurysms. Medtronic says that the Talent Abdominal Stent Graft expands the applicability of endovascular aneurysm repair (EVAR), enabling more patients to benefit from a minimally invasive alternative to open surgical repair. It is the only stent graft approved by the FDA for use in the treatment of abdominal aortic aneurysms with proximal necks ("landing zones") as short as 10 mm. EVAR involves the navigation of a stent graft – a fabric tube reinforced with a metal mesh – via the body's arteries to the aorta. The stent graft is then deployed, allowing blood flow through the aorta while reducing pressure on the aneurysm and the risk of rupture.

• Olympus Diagnostic Systems (Center Valley, Pennsylvania), a maker of in vitro diagnostics, reported the release of Hemoglobin A1c APT Reagent OSR61177 with fully automated on-board pre-treatment, for the determination of glycated hemoglobin in whole blood samples. HbA1c assays are commonly ordered laboratory tests used to ascertain blood glucose levels over a three-month period. The assay is designed for exclusive use on the Olympus AU680 chemistry analyzer system. The AU680 analyzer features enhanced whole blood sampling for Hemoglobin A1c testing, enabled by both advanced sample probe diving depth and enhanced sample probe washing. On-board pre-treatment is supported by the sample pre-diluting capability of the system.